Progress of retroperitoneal liposarcoma
10.3760/cma.j.cn115355-20240103-00007
- VernacularTitle:腹膜后脂肪肉瘤的研究进展
- Author:
Haofan ZHANG
1
;
Jiansheng GUO
Author Information
1. 山西医科大学第一临床医学院，太原 030012
- Publication Type:Journal Article
- Keywords:
Liposarcoma;
Retroperitoneal space;
Genome;
Molecular biology;
Diagnosis;
Therapy;
Prognosis
- From:
Cancer Research and Clinic
2025;37(3):236-240
- CountryChina
- Language:Chinese
-
Abstract:
The growth of retroperitoneal liposarcoma is occult, and generally there are no obvious clinical symptoms and signs in the early stage. The clinical and pathological features of primary retroperitoneal liposarcoma are not obvious, which lead to the difficulty of early diagnosis, low surgical resection rate and high postoperative recurrence rate. The effect of radiotherapy and chemotherapy on retroperitoneal liposarcoma is still controversial. In recent years, the researches of genomics and immunohistochemistry have gradually increased, and the related targeted therapies derived from these researches have also shown some preferable results, which provide new ideas for the diagnosis and treatment of retroperitoneal liposarcoma.
